Search companies

Live

Tuesday, 17 November 2026 · 578 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

PYC Therapeutics Director Rohan Hockings Buys Shares on Market

PYC: $1.80 -5.26% · MC: $1.9B

PYC Therapeutics director Rohan Hockings bought shares on market for approximately $206,000, increasing his direct ordinary shareholding by nearly 39%. The purchase follows director Peter Coleman's on-market acquisition of shares for approximately $202,000 last week. Hockings is also due to receive options and restricted rights under incentive plans, subject to shareholder approval.

Source announcements: 2026-11-03 16:09 to 2026-11-03 16:09 Sydney time
Story updated 2026-11-03 16:12 Sydney time
SourcesChange of Director's Interest Notice
Comments